According to Gelonghui on December 18, Iflytek Co.,ltd. (002230.SZ) announced that on December 18, 2024, its subsidiary Iflytek Medical will publish and distribute the prospectus for this issuance of H shares in accordance with relevant regulations on the Hong Kong Stock Exchange website. This H share prospectus is published in accordance with applicable Hong Kong laws and regulations as well as the relevant specifications and requirements of the Hong Kong Stock Exchange and the Hong Kong Securities and Futures Commission. Some of its contents may differ from related documents previously prepared or published by Iflytek Medical according to Chinese laws and regulations, including but not limited to the accountant's report prepared in accordance with international accounting standards included in the prospectus, which is intended solely to provide news to the public in Hong Kong and qualified investors. A-share investors should refer to the relevant information and announcements disclosed in the domestic newspapers and designated information disclosure websites of regulatory authorities. The H shares issued by Iflytek Medical are expected to be listed and begin trading on the Hong Kong Stock Exchange on December 30, 2024.
The number of H shares for the global offering by Iflytek Medical is set at 7,035,550 shares (subject to adjustments due to the allotment and exercise of the over-allotment option). Of these, the initial allocation for the Hong Kong public offering is 703,600 shares (subject to re-allocation), accounting for approximately 10% of the total global offering; the international offering is 6,331,950 shares (subject to re-allocation and the exercise of the over-allotment option), accounting for approximately 90% of the total global offering. Within 30 days after the listing date and the deadline for the Hong Kong public offering, the overall coordinator (representing the international underwriters) may also require Iflytek Medical to issue and allocate up to 1,055,300 additional H shares at the offer price by exercising the over-allotment option. If the over-allotment option is fully exercised, the maximum number of H shares issued globally by Iflytek Medical will be 8,090,850 shares. The price for the H share issuance by Iflytek Medical is set at HK$82.8. The Hong Kong public offering of Iflytek Medical's H shares will start on December 18, 2024, and is expected to end on December 23, 2024.
